Catalent to offer GSK-developed compound optimisation platform
Catalent Pharma Solutions is offering Optiform, a GSK developed compound optimisation platform, to researchers for the first time.
Catalent Pharma Solutions is offering Optiform, a GSK developed compound optimisation platform, to researchers for the first time.
Outsourcing-pharma presents a round-up of recent developments in the contract research sector, with news from Quintiles, Bioclinica and Cyprotex.
Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”